Skip to content

Clinical trials

Neurotoxicity Syndromes trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurotoxicity Syndromes Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20133
20152
20171
20191
20201
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed2
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tianjin Medical University Cancer Institute and Hospital3
Fudan University2
Sun Yat-sen University2
Northern Jiangsu People's Hospital1
Peking University Cancer Hospital & Institute1
Shantou University Medical College1
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1
The First Affiliated Hospital of Dalian Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurotoxicity Syndromes12
Colorectal Neoplasms2
Gastrointestinal Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Lead Poisoning1
Peripheral Nervous System Diseases1
Stomach Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.